Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones inMycobacterium tuberculosis

SpecificgyrAgene mutations predict poor treatment outcome in MDR-TB

(2015) L. Rigouts et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

High Proportion of Heteroresistance ingyrAandgyrBin Fluoroquinolone-Resistant Mycobacterium tuberculosis Clinical Isolates

(2014) Brandon Eilertson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mechanisms of fluoroquinolone monoresistance inMycobacterium tuberculosis

(2014) Jie Lu et al.   FEMS MICROBIOLOGY LETTERS

Successful ‘9-month Bangladesh regimen’ for multidrug-resistant tuberculosis among over 500 consecutive patients

(2014) K. J. M. Aung et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin

(2014) Pooja Singh et al.   JOURNAL OF ANTIBIOTICS

A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis

(2014) Corinne S. Merle et al.   NEW ENGLAND JOURNAL OF MEDICINE

First Evaluation of Drug-Resistant Mycobacterium tuberculosis Clinical Isolates from Congo Revealed Misdetection of Fluoroquinolone Resistance by Line Probe Assay Due to a Double Substitution T80A-A90G in GyrA

(2014) Alexandra Aubry et al.   PLoS One

Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis

(2014) Jing Li et al.   Emerging Microbes & Infections

Treatment outcomes and moxifloxacin susceptibility in ofloxacin-resistant multidrug-resistant tuberculosis

(2013) K-W. Jo et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Can Molecular Methods Detect 1% Isoniazid Resistance in Mycobacterium tuberculosis?

(2013) D. B. Folkvardsen et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Rifampin Resistance Missed in Automated Liquid Culture System for Mycobacterium tuberculosis Isolates with Specific rpoB Mutations

(2013) L. Rigouts et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Digital PCR to Detect and Quantify Heteroresistance in Drug Resistant Mycobacterium tuberculosis

(2013) Suporn Pholwat et al.   PLoS One

Mycobacterium tuberculosis Population Structure Determines the Outcome of Genetics-Based Second-Line Drug Resistance Testing

(2012) E. M. Streicher et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa

(2012) Halima M Said et al.   BMC INFECTIOUS DISEASES

Diagnostic Accuracy and Reproducibility of WHO-Endorsed Phenotypic Drug Susceptibility Testing Methods for First-Line and Second-Line Antituberculosis Drugs

(2012) D. J. Horne et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin

(2012) E. Y. Nosova et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Evaluation of BACTEC MGIT 960 system for the second-line drugs susceptibility testing of Mycobacterium tuberculosis in China

(2012) Li-li Zhao et al.   JOURNAL OF MICROBIOLOGICAL METHODS

New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations

(2012) Seidu Malik et al.   PLoS One

Efflux as a mechanism for drug resistance inMycobacterium tuberculosis: Table 1

(2011) Pedro Eduardo Almeida da Silva et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis

(2011) A. Martin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis

(2010) Armand Van Deun et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Should Moxifloxacin Be Used for the Treatment of Extensively Drug-Resistant Tuberculosis? An Answer from a Murine Model

(2010) J. Poissy et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment Outcomes among Patients with Extensively Drug‐Resistant Tuberculosis: Systematic Review and Meta‐Analysis

(2010) Karen R. Jacobson et al.   CLINICAL INFECTIOUS DISEASES

Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data

(2010) K. A. Angeby et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Comparative Study on Genotypic and Phenotypic Second-Line Drug Resistance Testing of Mycobacterium tuberculosis Complex Isolates

(2010) J. van Ingen et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Detection by GenoType MTBDRsl Test of Complex Mechanisms of Resistance to Second-Line Drugs and Ethambutol in Multidrug-Resistant Mycobacterium tuberculosis Complex Isolates

(2010) F. Brossier et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China

(2010) Xiaomao Yin et al.   JOURNAL OF INFECTION

Fluoroquinolone Resistance in Mycobacterium tuberculosis and Mutations in gyrA and gyrB

(2009) A. Von Groll et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results

(2009) A. Van Deun et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Feasibility of the GenoType MTBDRsl Assay for Fluoroquinolone, Amikacin-Capreomycin, and Ethambutol Resistance Testing of Mycobacterium tuberculosis Strains and Clinical Specimens

(2009) D. Hillemann et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Molecular Characterization of Ofloxacin-Resistant Mycobacterium tuberculosis Strains from Russia

(2008) I. Mokrousov et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY